Talk to us
Ventana Life
Investor Focus Health & Research
Media Center
Company Our Brands Our Purpose Our Community
Health and Research
Health and Research



Ventana is uniquely capable of developing and communicating these new food choices in the context of general health and nutrition education highlighted by on research and product development.

The need for natural healthy products that address the growing overweight and diabetic general populations is reflected in the following table:

Consumer Information United States
Population 287,000,000
% Adults Overweight 67%
% Children & Adolescents Overweight 25%
Overweight 192,300,000
Individuals with Diabetes 17,000,000
Estimated Diabetics 2050 29,000,000
Incidence of Diabetes (age 45-64) 7.8%
Incidence of Diabetes by Age 65 12.0%

      - UCLA Center for Health Policy Research
      - US Centers for Disease Control and Prevention (October 2003, Nutraceuticals         World)


The U.S., and particularly the Latino segment, is facing an ever-increasing obesity and diabetes problem.  Experts agree that the diabetic problems are often traced to the over weight condition of the patient.

The U.S. Surgeon General has declared that obesity has replaced smoking as the leading health risk to Americans—and it is a worldwide epidemic. 

“Food Technology” (April 2003) highlights Ventana weight loss opportunities:
Ventana Life Health-motivated diet segment
Ventana Life Need for products directed at children (only 1 of 3 teens is satisfied with their weight)
Ventana Life Timing is right for a new generation of low-/high-micro and macronutrient products aimed at
weight loss
Ventana Life Amount of weight needed to be lost is the highest in history

Ventana’s long-term objectives are to develop a series of products and services in support of the “Window on Health”—a lifestyle of health and sustainability for the Latino population. 

 

Ventana Life Erythritol: A new All-Natural and Noncaloric Bulk Sweetener - VIEW
Ventana Life Effects of Oral Administration of Erythritol on Patients with Diabetes - VIEW
Ventana Life Erythritol: A Review of Biological and Toxicological Studies - VIEW
Ventana Life Erythritol: An Interpretive Summary of Biochemical, Metabolic, Toxicological and
    Clinical Data -
VIEW
Ventana Life Gastrointestinal Response and Plasma and Urine Determinations in Human
    Subjects Given Erythritol -
VIEW
Ventana Life Plasma and Urine Kinetics of Erythritol after Oral Ingestion by Healthy
    Humans -
VIEW
Ventana Life Tolerance to Subchronic, High-Dose Ingestion of Erythritol in Human
    Volunteers -
VIEW


© COPYRIGHT 2006 VENTANA HEALTH INC, ALL RIGHTS RESERVED